Neurontin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0071-2012 -
Package NDC
0071-2012-47 -
Application number
NDA021129 -
SPL ID
e730d5df-d47b-4d7f-ae3b-bd449f6b1213 -
SPL set ID
ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388 -
UNII
6CW7F3G59X -
RxCUI
105028 -
RxCUI
105029 -
RxCUI
105030 -
RxCUI
261280 -
RxCUI
261281 -
RxCUI
283523 -
RxCUI
310430 -
RxCUI
310431 -
RxCUI
310432 -
RxCUI
310433 -
RxCUI
310434 -
RxCUI
351973
What the source publishes
- Labeler
- Parke-Davis Div of Pfizer Inc
- Active ingredients
- gabapentin
- Form
- SOLUTION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Neurontin",
"splId": "e730d5df-d47b-4d7f-ae3b-bd449f6b1213",
"labels": [
{
"setId": "ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388"
}
],
"routes": [
"ORAL"
],
"labeler": "Parke-Davis Div of Pfizer Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BOTTLE, PLASTIC in 1 CARTON (0071-2012-47) / 470 mL in 1 BOTTLE, PLASTIC",
"package_ndc": "0071-2012-47",
"identifierStatus": "well-formed",
"marketing_end_date": "20270131",
"marketing_start_date": "20220712"
}
],
"productId": "0071-2012_e730d5df-d47b-4d7f-ae3b-bd449f6b1213",
"useDomain": "unknown",
"dosageForm": "SOLUTION",
"productNdc": "0071-2012",
"deaSchedule": null,
"genericName": "gabapentin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20270131",
"activeIngredients": [
{
"name": "GABAPENTIN",
"strength": "250 mg/5mL"
}
],
"applicationNumber": "NDA021129",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20000302",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486"
],
"upc": [
"0300710513242"
],
"unii": [
"6CW7F3G59X"
],
"rxcui": [
"105028",
"105029",
"105030",
"261280",
"261281",
"283523",
"310430",
"310431",
"310432",
"310433",
"310434",
"351973"
],
"spl_set_id": [
"ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"manufacturer_name": [
"Parke-Davis Div of Pfizer Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0071-2012_e730d5df-d47b-4d7f-ae3b-bd449f6b1213"